首页> 外文会议>Computer, Consumer and Control (IS3C), 2012 International Symposium on >Evaluation of Intelligent System to the Control of Diabetes
【24h】

Evaluation of Intelligent System to the Control of Diabetes

机译:糖尿病控制智能系统评估

获取原文
获取原文并翻译 | 示例

摘要

Diabetes, as the 4th death cause, has become a vital issue in the 21th century. However, blood sugar levels of most diabetic patients are not well controlled. For a patient with chronic disease, treatment efficiency could be influenced by the disease, remedy, and mental condition, in addition to his/her physiological status. Therefore, there is a great deal of difficulty in establishing a guideline to decide the reasonable dosage for a particular patient. To address this difficulty, this study, via team cooperation with the Department of Endocrinology and Metabolism, Taichung Hospital, has designed an artificial intelligence (AI) system. This AI system may provide a real-time monitoring of patient¡¦s physical condition and adjust the insulin dosage from AI system to facilitate the monitoring, caring, and management of patients. Furthermore, abnormal condition may be detected earlier and then emergency treatment may be provided in time to prevent the occurrence of any unfortunate events caused by negligence. With this system, data of 4 patients was partitioned into training data set (3/2) and test data set (1/3). Training data set was entered into ANM system for an analysis of learning stage to build a prediction model for insulin dosage. Upon the completion, the test data set was tested with this prediction model for the accuracy of dosage control by bioartificial pancreas. Results showed that ANM system may effectively predict the occurrence of problems related to insulin dosage of bioartificial pancreas, with a satisfactory accuracy.
机译:糖尿病作为第四大死亡原因,已成为21世纪的重要问题。但是,大多数糖尿病患者的血糖水平没有得到很好的控制。对于患有慢性疾病的患者,除了其生理状态外,治疗效率还可能受疾病,治疗方法和精神状况的影响。因此,在建立指南以决定特定患者的合理剂量方面存在很大困难。为了解决这一难题,本研究通过与台中医院内分泌代谢科的团队合作,设计了一个人工智能(AI)系统。该AI系统可以提供对患者身体状况的实时监控,并可以通过AI系统调整胰岛素剂量,以方便对患者的监控,护理和管理。此外,可以更早地发现异常状况,然后可以及时提供紧急治疗以防止由于疏忽而引起的任何不幸事件的发生。使用该系统,将4位患者的数据分为训练数据集(3/2)和测试数据集(1/3)。将训练数据集输入ANM系统以分析学习阶段,以建立胰岛素剂量预测模型。完成后,使用该预测模型测试测试数据集的生物人工胰腺控制剂量的准确性。结果表明,ANM系统可以有效地预测与生物人工胰腺的胰岛素剂量有关的问题的发生。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号